|
Wednesday 1st July 2020 |
Text too small? |
AFT Pharmaceuticals Limited (NZX: AFT /ASX:AFP) (AFT) announced today that its NZ$2 million share purchase plan (SPP) has closed oversubscribed. The SPP received strong shareholder support with AFT receiving applications totalling approximately NZ$9.8 million. Applications will be scaled on a proportionate basis in accordance with the number of AFT shares held by applicants on the SPP record date (9 June 2020). Refunds of surplus application amounts paid will be made to applicants in accordance with the terms of the SPP offer document. See link below for detail.
No comments yet
AIA - launches retail bond offer and wholesale bond offer
WCO - Settlement of Navaa Holdings Investment Stage 1
Devon Funds Morning Note - 04 November 2026
MFB - My Food Bag completes review and confirms plan
PEB - Interim Financial Result to be Announced 24 November 2026
November 4th Morning Report
November 3rd Morning Report
LOC - Bitcoin Holding Converted to Cash
CEN - Contact launches green Capital Bond Offer
Anthropic asks investors to trust it won't do evil